BOSTON, Sept. 8, 2016 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), developer of the Dario™ Blood Glucose
Monitoring System, today announced that it is adapting its flagship
product to also incorporate use with the new Apple®
iPhone® 7. After receiving regulatory clearance for
marketing by the U.S. Food and Drug Administration and other
applicable regulatory agencies in Canada, Europe and Australia, customers will be able to select
which DarioHealth product they require for connection to their
smartphone.
The long-standing rumor that Apple's new iPhone 7 would come
without a traditional headphone jack in favor of their
Lightning® connector was confirmed by Apple, leaving out
many products that depend on the headphone jack for connectivity.
The Dario™ Blood Glucose Monitoring System, which launched a
direct-to-consumer model earlier in the year, relies on connecting
its proprietary meter to a smartphone via the headphone jack.
"This news comes as no surprise to us, and we've been working on
a solution for quite some time now," said Erez Raphael, DarioHealth's Chief Executive
Officer. "Our team's agility to navigate the complex mobile
ecosystem showcases DarioHealth's versatility and passion to be at
the forefront of cutting-edge technology in general, and the
diabetes healthcare market specifically."
There is no timeframe when the new Dario™ Blood Glucose
Monitoring System, compatible for use with the iPhone 7, will be
commercially available; however, Mr. Raphael confirmed that the
footprint and packaging for the product would be the same.
Mr. Raphael concluded, "The Dario™ Blood Glucose Monitoring
System has received rave reviews from our users, and we are
committed to providing an accurate, extraordinary product that can
be discreetly tucked away in a backpack, pocket, or purse. This is
important to our users and therefore, the updated meter compatible
with the iPhone 7 will be the same size as our current meter and
fit into the same all-in-one carrying device.
"Once we receive the proper regulatory clearances and approvals
our Customer Support organization will help transition current
users who move to the iPhone 7 and answer any questions new users
may have about the product."
For more information on how DarioHealth is driving the mobile
digital health market and how their product aims to be compatible
with Apple's iPhone 7, please visit:
www.mydario.com/iphone7-lightning/
Apple, iPhone and Lightning are registered trademarks of Apple
Inc.
About DarioHealth
DarioHealth is a leader in digital health self-management
solutions. DarioHealth delivers the ability to combine and analyze
consumer health data to personalize treatment and advance medical
knowledge. The Dario™ Blood Glucose Monitoring System is a platform
for diabetes management that combines an all-in-one blood glucose
meter, native smart phone app, website portal and a wide variety of
treatment tools to support more proactive and better informed
decisions by users living with diabetes, their doctors and
healthcare systems. Having recently launched in the largest
market in the world for glucose monitoring, U.S. sales are expected
to have a significant impact on revenues and gross margins. With
marketing clearance in Europe and the U.S., the Dario iOS
mobile app recently launched with reimbursement in the United
Kingdom, Australia, Israel, Italy, and Canada,
and has also launched in New
Zealand, Netherlands, Italy, and Belgium. For more
information, visit: http://mydario.investorroom.com/
Cautionary Note Regarding Forward-Looking Statements
This press release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when the Company
describes its products' compatibility with the iPhone 7, regulatory
approvals, and that U.S. sales are expected to have a significant
impact on revenues and gross margins. Readers are cautioned
that certain important factors may affect the Company's actual
results and could cause such results to differ materially from any
forward-looking statements that may be made in this news release.
Factors that may affect the Company's results include, but are not
limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
+1-800-896-9062
DarioHealth Investor Relations Contact
Hayden IR
Rob Fink / Brett Maas
DRIO@HaydenIR.com
+1-646-415-8972 / +1-646-536-7331
Logo - http://photos.prnewswire.com/prnh/20160802/395077LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dariohealth-preps-for-new-iphone-300324657.html
SOURCE DarioHealth Corp.